Medtronic MDT Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| $4.84B+3.1% | $4.64B+8.1% | $4.79B+10.8% | $4.69B+18.5% | $4.69B+26.6% | ||
| $2.96B+3.4% | $3.08B+15.2% | $3.02B+14.3% | $2.95B+11.8% | $2.86B+8.1% | ||
| $457M+6.5% | $451M+4.9% | $455M+9.4% | $432M+7.2% | $429M+9.2% | ||
| —— | —— | —— | -$237M+43.6% | -$316M+37.8% | ||
| $0— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $136M+10.6% | $129M+4.0% | $144M+46.9% | $133M+52.9% | $123M+36.7% | ||
| —— | —— | —— | —— | —— | ||
| $46M-78.0% | $289M-40.7% | $136M-64.5% | $215M-53.3% | $209M-46.5% | ||
| —— | —— | —— | —— | —— | ||
| $200M-53.8% | $162M-62.8% | $178M-60.9% | $255M-42.7% | $433M+10.7% | ||
| $7.33B+4.1% | $7.29B-0.1% | $7.11B-1.1% | $7.15B+3.6% | $7.04B+3.8% | ||
| $1.9B+2.4% | $1.88B+2.7% | $1.91B+12.4% | $1.84B+5.1% | $1.86B+17.1% | ||
| —— | —— | —— | —— | —— | ||
| $8.73B+6.1% | $8.71B+3.4% | $8.41B+0.5% | $8.45B+9.5% | $8.23B+6.2% | ||
| $8.11B-4.6% | $8.22B-3.9% | $8.12B-3.9% | $8.35B+6.3% | $8.5B+14.2% | ||
| —— | $148M-31.8% | $236M+17.4% | $357M+36.8% | $249M-4.6% | ||
| -$2.93B-51.5% | -$2.51B-17.0% | -$2.53B-26.3% | -$2.4B-14.9% | -$1.94B+18.1% | ||
| $3.64B+1.4% | $3.63B+0.6% | $3.61B-0.3% | $3.6B-1.2% | $3.59B-2.1% | ||
| $1.04B-68.0% | $874M-81.0% | $950M-79.1% | $866M-80.7% | $3.24B+51.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $2.93B— | $1.16B— | $0— | ||
| $516M+1.6% | $527M+10.3% | $531M+44.7% | $514M+73.6% | $508M+78.9% | ||
| —— | —— | —— | -$99M— | -$184M— | ||
| —— | —— | —— | —— | —— | ||
| -$4.75B-8.9% | -$5.21B+3.2% | -$4.87B+4.9% | -$5.01B-7.1% | -$4.36B+2.0% | ||
| —— | —— | —— | $224M— | $188M— | ||
| —— | —— | —— | -$38M-35.7% | $934M+461% | ||
| $774M+1.6% | $768M-6.9% | $791M-8.3% | $724M-15.9% | $762M-7.7% | ||
| $1.94B+6.8% | $1.9B+9.7% | $1.88B+1.7% | $1.83B-3.8% | $1.82B+12.1% | ||
| $0— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $200M-53.8% | $162M-62.8% | $178M-60.9% | $255M-42.7% | $433M+10.7% | ||
| -$314M-1.3% | -$576M-78.9% | -$575M-96.2% | -$478M-11.4% | -$310M+45.9% | ||
| $136M+10.6% | $129M+4.0% | $144M+46.9% | $133M+52.9% | $123M+36.7% | ||
| —— | $148M-31.8% | $236M+17.4% | $357M+36.8% | $249M-4.6% | ||
| $8.11B-4.6% | $8.22B-3.9% | $8.12B-3.9% | $8.35B+6.3% | $8.5B+14.2% | ||
| $538M— | $403.5M— | $269M— | $134.5M— | $0— | ||
| —— | $527M+10.3% | $531M+44.7% | $514M+73.6% | $508M+78.9% | ||
| —— | —— | —— | -$99M— | -$184M— | ||
| —— | —— | —— | —— | —— | ||
| $1.94B+6.8% | $1.9B+9.7% | $1.88B+1.7% | $1.83B-3.8% | $1.82B+12.1% | ||
| $5.43B+4.6% | $5.41B-1.0% | $5.21B-5.3% | $5.3B+3.1% | $5.19B-0.3% | ||
| $5.43B+4.6% | $5.41B-1.0% | $5.21B-5.3% | $5.3B+3.1% | $5.19B-0.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Medtronic generate?
- Medtronic (MDT) generated $7.3B in operating cash flow over the trailing twelve months.
- What is Medtronic's free cash flow?
- After $1.9B of capital expenditures, Medtronic's free cash flow was $5.4B over the trailing twelve months, up 4.7% year over year.
- Where does Medtronic's cash flow data come from?
- Every line is extracted from Medtronic's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
